Finance

Lists
Why is 1OT up 5.88%?
Dive Deeper
1OT:FRA
Ovid Therapeutics Inc
€2.16
+5.88%
(+0.12) 1D
Oct 12, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1OT...
Open
€2.16
High
€2.16
Low
€2.16
Mkt. cap
470.67M
Avg. vol.
2.00
Volume
0.00
52-wk high
€2.52
52-wk low
€0.97
No. of employees
23
Open
€2.16
High
€2.16
Low
€2.16
Mkt. cap
470.67M
Avg. vol.
2.00
Volume
0.00
52-wk high
€2.52
52-wk low
€0.97
No. of employees
23
News stories
From web sources and news partners
About Ovid Therapeutics Inc
CEO-
Employees23
Founded2014
Headquarters-
SectorBiotechnology
Websiteovidrx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
132.00K
718.00K
-
733.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.87M
6.59M
11.18M
9.96M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.78M
6.42M
6.66M
6.17M
Operating expense
12.66M
13.01M
17.85M
16.13M
Total operating expenses
12.66M
13.01M
17.85M
16.13M
Operating income
-12.52M
-12.29M
-17.85M
-15.40M
Other non operating income
62.00K
57.00K
121.00K
-869.00K
EBT including unusual items
-12.16M
9.66M
-16.99M
-15.01M
EBT excluding unusual items
-12.16M
-11.39M
-16.99M
-14.71M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-12.16M
9.66M
-16.99M
-15.01M
Net profit margin
-9,210.61%
1,345.82%
-
-2,047.61%
Earnings per share
-0.17
0.06
-0.12
-0.08
Interest and investment income
303.00K
847.00K
737.00K
1.56M
Interest expense
-
-
-
-
Net interest expenses
303.00K
847.00K
737.00K
1.56M
Depreciation and amortization charges
-
-
-
-
EBITDA
-12.51M
-12.28M
-17.81M
-15.38M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps